Saroglitazar Dosage for Primary Biliary Cholangitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis
J. Hepatol. 2022 Jan 01;76(1)75-85, R Vuppalanchi, SH Caldwell, N Pyrsopoulos, AS deLemos, S Rossi, C Levy, DS Goldberg, EA Mena, A Sheikh, R Ravinuthala, F Shaikh, JD Bainbridge, DV Parmar, NP ChalasaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.